Coronavirus (COVID-19) Update: FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses
FDA Statement The following is attributed Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research For Immediate Release: June 30, 2022 Statement From: Peter Marks, M.D., PhD. Director - Center for Biologics Evaluation …